MD Biosciences offers biomarker analysis and validation services for a variety of samples from in vitro, in vivo and ex vivo preclinical studies as well as human clinical trials. Biomarker studies encompass detection of disease-specific analytes of interest utilizing a variety of methods such as multiplex protein analysis, ELISA, Western blotting, qPCR, FACS, IHC/ISH and others. Our biomarker division can utilize off-the-shelf assays, transfer and validate externally developed assays to our laboratory or develop custom assays from scratch to meet unique analytical requirements. We employ rigorous QA/QC measures, including a dedicated Quality Management team and Total Quality Management System, ensuring the rigor and reliability of results required for pharmaceutical and diagnostic/prognostic development programs.
Each biomarker study run with MD Biosciences can be customized to meet the unique specifications of our Sponsors, and Sponsor's can select from pre-formed panels based on common expression profiles (Th1, Th2, Treg etc) or disease states (inflammation, cardiac, metabolic etc).
Available Sample Submission Formats:
Dont see the biomarker service your interested in? Contact us to discuss a custom solution with our biomarker experts.